Technavio’s research report on the global intracranial pressure monitoring devices market for the period from 2019 to 2023 sees this market posting a CAGR of close to 7% during the forecast period. A driving factor for growth of the market is an increase in FDA approved products. The competition among vendors results in the launch of FDA approved products and improved intracranial pressure monitoring devices such as IRRAflow by IRRAS and Vittamed 205 by Vittamed.
The research report provides an analysis of the most important trends expected to impact the market outlook during the forecast period. Technavio classifies an emerging trend as a major factor that has the potential to significantly impact the market and contribute to its growth or decline.
- Global intracranial pressure monitoring devices market driven by rising advances in technology
- Report segments the global intracranial pressure monitoring devices market by product (invasive and non-invasive) and geographical regions (APAC, EMEA, and the Americas).
- The Americas led the market in 2018 with a market share of 48%, followed by EMEA and APAC respectively. The dominance of the Americas can be attributed to the increase in regulatory approvals for products.
Need more information on this market? Request a free sample report.
UK: +44 203 893 3200